Chronic myeloid leukemia
CML is a myeloproliferative disease characterized by excessive production of granulocytes (including mature and immature granulocytes). In the early stages of the disease, these cells still have the ability to differentiate and bone marrow function is normal. The disease often remains stable for several years and eventually turns into a more malignant disease. Most patients with this disease are between 30 and 40 years old, and those under 20 are rare.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Most common in people over 50 years old -
Related symptoms:
Abnormal blood count fatigue low fever night sweats weight loss -
Concurrent disease:
Related Drugs
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission period and continuing treatment period of acute lymphocytic leukemia and acute non-lymphocytic leukemia; 2. The chronic phase and blast crisis phase of chronic myeloid leukemia.
Manufacturer:
Beijing Jialin Pharmaceutical Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:
Zhejiang Zhebei Pharmaceutical Co., Ltd.
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:
Sinopharm A-Think Pharmaceutical Co., Ltd.